3Ј-C-Branched Locked Nucleic Acid Thymidine Monomer
was washed with a saturated aqueous solution of NaHCO3
(3ϫ10 mL), dried (Na2SO4) and concentrated under reduced pres-
sure. The residue was purified by silica gel column chromatography
(0–22% ethyl acetate in petroleum ether) to give 15 (540 mg, 71%)
as a clear viscous oil: Rf = 0.45 (1:1, ethyl acetate/petroleum ether).
1H NMR (300 MHz, CDCl3): δ = 7.96–7.94 (m, 2 H, Ph), 7.54–
7.50 (m, 1 H, Ph), 7.41–7.24 (m, 12 H, Ph), 5.89 (d, J = 4.2 Hz, 1
H, 1-H), 5.06 (d, J = 12.6 Hz, 1 H, 5Ј-H), 4.82 (d, J = 10.8 Hz, 1
H, CH2Ph), 4.71–4.65 (m, 2 H, CH2Ph), 4.63 (d, J = 4.2 Hz, 1 H,
2-H), 4.55 (d, J = 12.0 Hz, 1 H, CH2Ph), 4.45 (d, J = 12.6 Hz, 1
H, 5Ј-H), 3.89 (d, J = 6.9 Hz, 2 H, 1Ј-H), 3.88–3.83 (m, 2 H, 5-H),
3.67 (t, J = 6.9 Hz, 1 H, 1Ј-OH), 1.66 (s, 3 H, CH3), 1.34 (s, 3 H,
CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 4.2 Hz, H-1), 5.02 (d,
1 H, J = 12.0 Hz), 4.82–4.65 (m, 4 H), 4.45–4.25 (m, 4 H), 3.85–
3.65 (m, 3 H), 3.58 (d, 1 H, J = 9.9 Hz), 1.62 (s, 3 H, CH3), 1.32
(s, 3 H, CH3). 13C NMR (75 MHz, CDCl3): δ = 166.4 (CO), 139.1,
137.8, 137.4, 132.7, 130.6, 129.8, 128.6, 128.4, 128.3, 128.2, 128.1,
128.0, 127.7, 127.2, 127.0, 126.9 (Ph), 113.5 [C(CH3)2], 104.9 (C-
1), 87.3, 85.5, 82.8, 73.7, 73.5, 69.8, 68.7, 68.0, 64.8 (C-2, C-3, C-
4, C-5, C-5Ј, C-1Ј, 3ϫ CH2Ph), 26.7 (CH3), 26.5 (CH3) ppm. HR-
MALDI MS: m/z 647.2596 ([M + Na]+, C38H40O8Na+ calcd.
647.2615).
= 12.0 Hz, 2 H), 4.39, 4.25 (AB, J = 11.4 Hz, 2 H), 3.98–3.67 (m,
4 H), 2.07 (s, 3 H, COCH3), 1.42 (s, 3 H, CH3) ppm. 13C NMR
(75 MHz, CDCl3): δ = 170.3 (COCH3), 166.2 (COPh), 163.6 (C-4),
150.8 (C-2), 138.2 (C-6), 136.8, 136.7, 136.1, 133.1, 130.0, 129.8,
128.9, 128.7, 128.6, 128.5, 128.4, 128.2, 128.1, 127.8, 127.7, 127.6,
127.5 (Ph), 111.3 (C-5), 88.6, 84.1, 76.5, 73.8, 73.8, 73.6, 71.0, 67.8,
67.0, 66.6 (C-1Ј, C-2Ј, C-3Ј, C-4Ј, C-5Ј, C-1ЈЈ, C-5ЈЈ, 3ϫ CH2Ph),
20.8 (COCH3), 12.0 (CH3) ppm. HR-MALDI MS: m/z 757.2760
([M + Na]+, C42H42N2O10Na+ calcd. 757.2732).
1-[3,5-Di-O-benzyl-3-C-(benzyloxymethyl)-4-C-(hydroxymethyl)-β-
D
-ribofuranosyl]thymine (19): Sodium methoxide (134 mg,
2.48 mmol) was added to a solution of 18 (455 mg, 0.62 mmol) in
anhydrous methanol (5 mL), and the reaction mixture was stirred
for 2 h at room temperature. Excess of sodium methoxide was neu-
tralized with dilute aqueous hydrochloric acid. The mixture was
extracted with dichloromethane (2ϫ20 mL) and the combined ex-
tract was washed with a saturated aqueous solution of NaHCO3
(3ϫ15 mL), dried (Na2SO4), and concentrated under reduced pres-
sure. The residue was purified by silica gel column chromatography
(0–2% methanol in dichloromethane) to give nucleoside 19 as a
white foam (312 mg, 86%): Rf = 0.50 (9:1, CH2Cl2/CH3OH). 1H
NMR (300 MHz, CDCl3): δ = 8.50 (br. s, 1 H, NH), 7.62 (s, 1 H,
6-H), 7.38–7.18 (m, 15 H, Ph), 6.04 (d, J = 7.8 Hz, 1 H, 1Ј-H),
5.06, 4.87 (AB, J = 11.1 Hz, 2 H), 4.53, 4.36 (AB, J = 10.5 Hz, 2
H), 4.30–4.25 (m, 1 H), 4.27 (d, J = 7.8 Hz, 1 H, 2Ј-H), 4.20–4.10
(m, 2 H), 4.00 (dd, J = 4.2, 10.8 Hz, 1 H, 5ЈЈ-H), 3.86–3.82 (m, 1
H), 3.81, 3.72 (AB, J = 10.5 Hz, 2 H), 3.58 (dd, J = 8.7, 10.8 Hz,
1 H, 5ЈЈ-H), 3.50 (br. s, 1 H, 2Ј-OH), 2.87 (dd, J = 4.2, 8.7 Hz, 1
H, 5ЈЈ-OH), 1.48 (s, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 163.9 (C-4), 151.6 (C-2), 136.8 (C-6), 138.7, 136.3, 136.2, 128.8,
128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 127.9, 127.6, 127.5 (Ph),
111.1 (C-5), 90.0, 87.2, 84.1, 78.7, 73.8, 73.6, 72.7, 68.1, 67.0, 63.7
(C-1Ј, C-2Ј, C-3Ј, C-4Ј, C-5Ј, C-1ЈЈ, C-5ЈЈ, 3ϫ CH2Ph), 12.1 (CH3)
ppm. HR-MALDI MS: m/z 611.2379 ([M + Na]+, C33H36N2-
O8Na+ calcd. 611.2364).
1,2-Di-O-acetyl-4-C-(benzoyloxymethyl)-3,5-di-O-benzyl-3-C-(ben-
zyloxymethyl)-(α/β)-D-ribofuranose (17): Compound 16 (1.78 g,
2.85 mmol) was dissolved in 80% aqueous acetic acid (20 mL) and
the mixture was stirred for 3 h at 90 °C. The reaction mixture was
concentrated under reduced pressure and coevaporated with anhy-
drous ethanol (4 mL), toluene (4 mL) and pyridine (4 mL). The
residue was redissolved in anhydrous pyridine (20 mL) and acetic
anhydride (4.6 mL) was added dropwise. The reaction mixture was
stirred overnight at room temperature and quenched by the ad-
dition of ice-water (10 mL). The mixture was extracted with dichlo-
romethane (3 ϫ 10 mL) and the combined organic phase was
washed with a saturated aqueous solution of NaHCO3, dried
(Na2SO4) and concentrated under reduced pressure. The residue
was purified by silica gel column chromatography (0–16% ethyl
acetate in petroleum ether) to give 17 as a mixture of anomers
(1.73 g, 91%; β:α ≈2.5:1) as a clear viscous oil: Rf = 0.60 (1:1, petro-
(1S,3R,4R,7S)-1,7-Bis(benzyloxymethyl)-7-(benzyloxy)-3-(thymin-
1-yl)-2,5-dioxabicyclo[2.2.1]heptane (20): A solution of 19 (526 mg,
0.89 mmol) in anhydrous dichloromethane (3 mL) and anhydrous
pyridine (0.29 mL) was cooled to –40 °C. Methanesulfonyl chloride
(104 µL, 1.34 mmol) was added dropwise, and the mixture was
stirred at –40 °C to 0 °C for 7 h. Water (3 mL) was added followed
by a saturated aqueous solution of NaHCO3 (10 mL). The resulting
mixture was extracted with dichloromethane (3ϫ5 mL) and the
organic phase was dried (Na2SO4) and concentrated under reduced
pressure. The residue was dissolved in anhydrous 1,4-dioxane
(4 mL) and the solution was stirred at 10 °C. A 60% oil dispersion
of NaH (90 mg, 2.23 mmol) was added in one portion. The reac-
tion mixture was stirred at 50 °C for 12 h and then quenched by
the addition of a saturated aqueous solution of NH4Cl (2 mL).
The reaction mixture was extracted with CH2Cl2 (4ϫ5 mL). The
combined organic phase was dried (Na2SO4) and concentrated un-
der reduced pressure. The residue was purified by silica gel column
chromatography (0–3 % methanol in dichloromethane) affording
nucleoside 20 (369 mg, 72 %) as a white foam: Rf = 0.30 (19:1,
1
leum ether/ethyl acetate). H NMR (300 MHz, CDCl3): δ = 7.97–
7.93 (m, 2 H, Ph), 7.58–7.45 (m, 1 H, Ph), 7.40–7.23 (m, 17 H, Ph),
6.45 (d, J = 5.4 Hz, 1α-H), 6.28 (d, J = 3.0 Hz, 1β-H), 5.81 (d, J
= 3.0 Hz, 2β-H), 5.60 (d, J = 5.4 Hz, 2α-H), 4.83–4.60 (m), 4.55–
4.25 (m), 4.05–3.55 (m), 2.03, 2.00, 1.98, 1.97 (each s, CH3) ppm.
HR-MALDI MS: m/z 691.2481 ([M + Na]+, C39H40O10Na+ calcd.
691.2514).
1-[2-O-Acetyl-4-C-(benzoyloxymethyl)-3,5-di-O-benzyl-3-C-(benzyl-
oxymethyl)-β-D-ribofuranosyl]thymine (18): To a stirred solution of
17 (1.69 g, 2.52 mmol) and thymine (636 mg, 5.05 mmol) in anhy-
drous CH3CN (20 mL) was added N,O-bis(trimethylsilyl)acetamide
(3.12 mL, 12.62 mmol). The reaction mixture was stirred for
30 min. After cooling to 0 °C, trimethylsilyl triflate (1.37 mL,
7.57 mmol) was added dropwise, and the solution was stirred over-
night at 70 °C. After cooling to room temperature, the reaction
mixture was diluted with ethyl acetate (20 mL) and washed with a
saturated aqueous solution of NaHCO3 (3 ϫ10 mL). The com-
bined organic phase was dried (Na2SO4) and concentrated under
reduced pressure. The residue was purified by silica gel column
chromatography (0–2% methanol in dichloromethane) to give nu-
1
CH2Cl2/CH3OH). H NMR (300 MHz, CDCl3): δ = 8.22 (s, 1 H,
NH), 7.50 (d, J = 0.9 Hz, 1 H, 6-H), 7.36–7.11 (m, 15 H, Ph), 5.54
(s, 1 H, 1Ј-H), 5.39 (s, 1 H, 2Ј-H), 4.77, 4.70 (AB, J = 11.1 Hz, 2
H), 4.57 (s, 2 H), 4.24, 3.99 (AB, J = 7.5 Hz, 2 H), 4.20 (s, 2 H),
3.82–3.68 (m, 4 H), 1.87 (d, J = 0.9 Hz, 3 H, CH3) ppm. 13C NMR
cleoside 18 (1.72 g, 93%) as a white foam: Rf = 0.40 (19:1, CH2Cl2/
1
CH3OH). H NMR (300 MHz, CDCl3): δ = 8.37 (br. s, 1 H, NH), (75 MHz, CDCl3): δ = 163.5 (C-4), 149.8 (C-2), 138.3 (C-6), 137.7,
8.00–7.98 (m, 2 H, Ph), 7.66 (s, 1 H, 6-H), 7.55–7.25 (m, 18 H, Ph),
6.52 (d, J = 8.1 Hz, 1 H, 1Ј-H), 5.69 (d, J = 8.1 Hz, 1 H, 2Ј-H), 127.4 (Ph), 109.4 (C-5), 90.1 (C-4Ј), 89.0 (C-1Ј), 84.8 (C-3Ј), 78.1
4.90, 4.81 (AB, J = 10.5 Hz, 2 H), 4.74 (s, 2 H), 4.52, 4.32 (AB, J (C-2Ј), 74.6, 73.8, 73.8, 70.6, 69.3, 65.1 (C-5ЈЈ, C-1ЈЈ, C-5Ј, 3ϫ
137.0, 134.5, 128.6, 128.6, 128.4, 128.0, 128.0, 127.8, 127.7, 127.6,
Eur. J. Org. Chem. 2008, 5715–5722
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5721